⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ARTV News

Artiva Biotherapeutics, Inc. Common Stock

Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update